US Patent 8652470 Monoclonal antibodies directed to CD52
Patent 8652470 was granted and assigned to VET THERAPEUTICS, INC. on February, 2014 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8652470 Monoclonal antibodies directed to CD52
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
